NDVA.H Stock Overview Engages in the production, processing, and sale of cannabis and cannabis related products in Canada. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Indiva Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Indiva Historical stock prices Current Share Price CA$0.03 52 Week High CA$0.13 52 Week Low CA$0.03 Beta 1.08 1 Month Change 0% 3 Month Change -14.29% 1 Year Change -45.45% 3 Year Change -93.75% 5 Year Change -90.63% Change since IPO -97.60%
Recent News & Updates
SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining majority stake in Indiva Limited (TSXV:NDVA.H). Nov 06
Insufficient new directors Jul 16
Indiva Limited Announces Resignation of Rachel Goldman from the Board Jun 15
New major risk - Financial position Jun 07
Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity May 28 Indiva Limited Provides Earnings Guidance for the Second Quarter of 2024 May 24
See more updates
SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining majority stake in Indiva Limited (TSXV:NDVA.H). Nov 06
Insufficient new directors Jul 16
Indiva Limited Announces Resignation of Rachel Goldman from the Board Jun 15
New major risk - Financial position Jun 07
Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity May 28 Indiva Limited Provides Earnings Guidance for the Second Quarter of 2024 May 24
Indiva Limited to Report Q1, 2024 Results on May 23, 2024 May 16
Indiva Limited Provides Earnings Guidance for the First Quarter and Fiscal Year 2024 Apr 27
New major risk - Negative shareholders equity Apr 26
Full year 2023 earnings: Revenues and EPS in line with analyst expectations Apr 26
Indiva Limited to Report Q4, 2023 Results on Apr 25, 2024 Apr 17
New major risk - Market cap size Apr 07
Insufficient new directors Apr 01 Indiva Limited announced that it expects to receive CAD 4.312 million in funding Feb 28
Indiva Limited announced that it expects to receive CAD 4 million in funding Jan 22
Price target increased by 15% to CA$0.15 Jan 06
Indiva Limited Provides Revenue Guidance for Fourth Quarter of 2023 Nov 22
Third quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.018 loss in 3Q 2022) Nov 22
Indiva Limited to Report Q3, 2023 Results on Nov 21, 2023 Nov 04
Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry Sep 29
Is Indiva (CVE:NDVA) Using Debt In A Risky Way? Sep 17
Second quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.017 loss in 2Q 2022) Aug 31
Indiva Limited to Report Q2, 2023 Results on Aug 29, 2023 Aug 18
Indiva Limited Launches No Future Gummies and Vapes Aug 11
New minor risk - Shareholder dilution Jun 20
New major risk - Share price stability Jun 16 Indiva Limited announced that it expects to receive CAD 2.155617 million in funding from Canopy Growth Corporation May 31
Indiva Limited Provides Revenue Guidance for the Second Quarter of 2023 May 17
Indiva Limited, Annual General Meeting, Jul 18, 2023 May 12
Indiva Limited to Report Q1, 2023 Results on May 16, 2023 May 04
Is Indiva (CVE:NDVA) A Risky Investment? Apr 19
Full year 2022 earnings: EPS and revenues miss analyst expectations Apr 19
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Nov 22
Price target decreased to CA$0.50 Nov 16
Indiva Limited to Report Q3, 2022 Results on Nov 22, 2022 Nov 09
Indiva Limited Provides Revenue Guidance for the Second Half and Full Year of 2022 Aug 18
Second quarter 2022 earnings: EPS and revenues miss analyst expectations Aug 17
Indiva Limited to Report Q2, 2022 Results on Aug 16, 2022 Aug 09
Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022 Jun 28
Consensus estimates of losses per share improve by 62% May 25
Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022 May 20
Indiva Limited to Report Q1, 2022 Results on May 19, 2022 May 12
Price target decreased to CA$0.60 Apr 27
Full year 2021 earnings: EPS and revenues exceed analyst expectations Apr 27
Indiva Limited Provides Net Revenue Guidance for the First Quarter of 2022 Apr 27
Indiva Limited, Annual General Meeting, Jun 23, 2022 Apr 12 Indiva Limited to Report Fiscal Year 2021 Results on Apr 26, 2022
Is Indiva (CVE:NDVA) Using Too Much Debt? Feb 26
Indiva Limited Launches New Cannabis Edible Designed for MicroDosing Feb 25
Indiva Launches New Cannabis Edible Formulated for Night-Time Use Feb 16
Third quarter 2021 earnings released: CA$0.047 loss per share (vs CA$0.035 loss in 3Q 2020) Nov 18
Would Indiva (CVE:NDVA) Be Better Off With Less Debt? Sep 04
Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.029 loss in 2Q 2020) Aug 25
Indiva Limited Provides Revenue Guidance for the Second Half of 2021 Aug 25
First quarter 2021 earnings released: CA$0.025 loss per share (vs CA$0.029 loss in 1Q 2020) Jun 02
Full year 2020 earnings released: CA$0.16 loss per share (vs CA$0.14 loss in FY 2019) May 16 Indiva Limited to Introduce Two New Bhang Chocolate Flavours Nationally in Second Quarter of 2021
Indiva Limited Ships Wana Quick Gummies Mar 06
Indiva Limited Appoints Russell Wilson to the Board of Directors Mar 03
Indiva Limited announced that it has received CAD 11 million in funding from Sundial Growers Inc. Feb 24
Indiva Announces Extension to License Agreement with Wana Brands Inc Feb 19
Indiva Limited announced that it expects to receive CAD 11 million in funding from Sundial Growers Inc. Feb 17
New 90-day high: CA$0.49 Feb 10
New 90-day high: CA$0.28 Dec 31
Independent Director recently bought CA$65k worth of stock Dec 23
Indiva Limited Promotes Rob Carse to Chief Operating Officer Dec 12
Price target raised to CA$0.63 Dec 10
Analysts increase revenue estimates to CA$14.9m Dec 10
Would Indiva (CVE:NDVA) Be Better Off With Less Debt? Nov 30
Third quarter 2020 earnings released: CA$0.035 loss per share Nov 28
New 90-day low: CA$0.21 Nov 19
New 90-day low: CA$0.23 Nov 03
Indiva Secures Agreement with Medical Cannabis by Shoppers Inc Oct 14
Indiva Ships Wana Sour Gummies to Alberta, Saskatchewan, and Yukon Territory Oct 04
Indiva Ships Wana™ Sour Gummies to British Columbia Sep 24
Analysts update estimates Sep 16
Price target lowered to CA$0.55 Sep 15
First half earnings released Sep 02
Indiva Limited announced that it has received CAD 5.179499 million in funding from Marotta Investments Limited, Prairie Merchant Corporation, ATB Capital Markets Inc. Aug 11
New 90-day low - CA$0.27 Jul 22 Shareholder Returns NDVA.H CA Pharmaceuticals CA Market 7D 0% -1.2% -3.7% 1Y -45.5% -24.4% 15.0%
See full shareholder returns
Return vs Market: NDVA.H underperformed the Canadian Market which returned 12.5% over the past year.
Price Volatility Is NDVA.H's price volatile compared to industry and market? NDVA.H volatility NDVA.H Average Weekly Movement n/a Pharmaceuticals Industry Average Movement 12.0% Market Average Movement 8.2% 10% most volatile stocks in CA Market 17.6% 10% least volatile stocks in CA Market 2.9%
Stable Share Price: NDVA.H's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NDVA.H's volatility change over the past year.
About the Company Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers edibles, capsules and tablets, and vape products under the No Future, Pearls by gron, Bhang Chocolate, Indiva Doppio, Indiva Blips, and Indiva 1432 brands. Indiva Limited is based in Ottawa, Canada.
Show more Indiva Limited Fundamentals Summary How do Indiva's earnings and revenue compare to its market cap? NDVA.H fundamental statistics Market cap CA$5.86m Earnings (TTM ) -CA$4.44m Revenue (TTM ) CA$37.49m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) NDVA.H income statement (TTM ) Revenue CA$37.49m Cost of Revenue CA$26.54m Gross Profit CA$10.95m Other Expenses CA$15.39m Earnings -CA$4.44m
Last Reported Earnings
Mar 31, 2024
Earnings per share (EPS) -0.023 Gross Margin 29.21% Net Profit Margin -11.83% Debt/Equity Ratio -1,692.6%
How did NDVA.H perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/09/09 22:13 End of Day Share Price 2024/06/12 00:00 Earnings 2024/03/31 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Indiva Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Andrew Semple Echelon Wealth Partners Inc. Siddharth Rajeev Fundamental Research Corp. Rahul Sarugaser Raymond James Ltd.
Show 1 more analysts 
